Diagnos Laboratorium Utama Tbk. vs Vale Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Vale Indonesia Tbk. trades at Rp4,930 (market cap 51.96T, 9.15M 24h volume). The key difference: Vale Indonesia Tbk. is far larger — about 167.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Vale Indonesia Tbk. is more actively traded (9.15M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | INCO | |
|---|---|---|
Market Cap | 310.75B | 51.96T |
Volume | 963.6K | 9.15M |
Lot | 9.64K | 91.49K |
Turnover | 217.67M | 44.81B |
Average Price | 225.89 | 4,897.71 |
Value | 217.67M | 44.81B |
Indicative Equilibrium Price | 226 | 4,930 |
Indicative Equilibrium Volume | 1K | 7.39K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA
Read more on INCO →